Cannabivarin [CBV]

Cannabivarin (CBV) is considered a non-psychoactive cannabinoid, found in minor amounts in the hemp plant, Cannabis sativa. It is an analog of cannabinol (CBN) with a shorter side chain, and is an oxidation product of tetrahydrocannabivarin (THCV). CBV has not been scheduled by international conventions and is not scheduled at the federal level in the United States, though it could potentially be prosecuted under the Federal Analog Act if intended for human consumption.

Chemistry and Synthesis

• Cannabivarin lacks double bond isomers or stereoisomers.
• It has a unique chemical structure compared to other cannabinoids.
• Potential therapeutic effects are being explored.
• Laboratory synthesis is possible.
• Ongoing research aims to uncover its properties.

Legal Status

• Not scheduled by the Convention on Psychotropic Substances.
• Legal status varies by country and jurisdiction.
• Considered an analog of THC in some regions.
• Possession and sale for human consumption may lead to prosecution.
• Regulations are subject to change based on new findings.

United States Specifics

• Not federally scheduled in the U.S.
• Treated as analogous to THC under the Federal Analog Act.
• Legal status may differ among states.
• Research and legislative developments impact its legality.
• Enforcement efforts may focus on production and distribution.

Related Topics

• Cannabinoids and their effects.
• Cannabis cultivation and use.
• Medical cannabis applications.
• Scientific studies and publications related to cannabinoids.
• Differentiation between various cannabinoids.

References

• Research on synthetic cannabidiol, cannabichromene, and cannabivarin.
• Publication in the Journal of Pharmaceutical Sciences.
• Citation for further reading and verification.
• Archived legal document on Schedule I substances.
• Emphasis on accurate chemical distinction for research validity.

Cannabivarin Data Sources